VAERS 1950446
JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1822809 OR 211A
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 15.12.2021
- Impfdatum
- 27.11.2021
- Beginn
- 27.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Symptomtext
RECEIVED HALF DOSE FOR THEIR BOOSTER DOSE; OFF LABEL USE; This spontaneous report received from a health care professional concerned an 18 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient previously received covid-19 vaccine ad26.cov2.s vaccination from an unspecified manufacturer (suspension for injection, route of admin not reported, batch number: unknown, expiry: UNKNOWN) dose was not reported, 1 in total administered, (dose number in series: 1) for prophylactic vaccination and it was unknown whether patient had any adverse events. The patient received covid-19 vaccine ad26.cov2.s booster dose (suspension for injection, route of admin not reported, batch number: 1822809 OR 211A21A expiry: UNKNOWN) dose was not reported, 1 total administered (dose number in series: 2) on 27-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-NOV-2021, following vaccination with booster dose of covid-19 vaccine ad26.cov2.s, the patient received half dose for their booster dose and off label use (dose number in series: 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the received half dose for their booster dose and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211202193, 20211201450, 20211201286, 20211204104, 20211201179 and 20211201443.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -